2019 Advisory Board

 

Sven Kili, Head of Cell & Gene Therapy Development, GSK Sven Kili
Head of Cell & Gene Therapy Development
GSK

Bo Kara, Head Process Development, Cell Gene Therapy CMC, GSK Bo Kara
Head Process Development, Cell Gene Therapy CMC
GSK

Margo Roberts, Senior VP of Discovery Research, Kite, a Gilead Company Margo Roberts
Senior VP
Discovery Research, Kite, a Gilead Company 

Andre Choulika, CEO, Cellectis Andre Choulika
CEO
Cellectis

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics Eric Soller
Vice President of Corporate Development & Strategy
BlueRock Therapeutics

Stephen Badylak, Professor, Department of Surgery, Director, McGowan Center of Pre-Clinical Studies, Deputy Director, McGowan Institute for Regenerative Medicine (MIRM) Stephen Badylak
Professor, Department of Surgery, Director, McGowan Center of Pre-Clinical Studies, Deputy Director, McGowan Institute for Regenerative Medicine ( MIRM )

Robert Beckman, Managing Partner, The Channel Group; Director of Business Development, Orgenesis Robert Beckman
Managing Partner, The Channel Group; Director of Business Development
Orgenesis

Norio Nakatsuji, Professor Emeritus, Kyoto University & Chief Advisor, Stem Cell & Device Laboratory, Inc Norio Nakatsuji
Professor Emeritus, Kyoto University & Chief Advisor
Stem Cell & Device Laboratory, Inc

Ohad Karnieli, Chair, Process and Product Development Subcommittee, ISCT; CEO & Co-Founder, ATVIO Biotechnology Ohad Karnieli
Chair, Process and Product Development Subcommittee, ISCT ; CEO & Co-Founder, ATVIO Biotechnology

Steven Pincus, Associate Vice President Virology and Analytical Methods Development, Fujifilm Diosynth Biotechnology Steven Pincus
Associate Vice President Virology and Analytical Methods Development
Fujifilm Diosynth Biotechnology

Claudia Mitchell, Chief Executive Officer, Universal Cells Inc. Claudia Mitchell
Chief Executive Officer
Universal Cells Inc.

Alain Vert├Ęs, Managing Director, NxR Biotechnologies Alain Vertès
Managing Director
NxR Biotechnologies

TBC: Annie Hubert, Director, European Public Policy, Alliance for Regenerative Medicine TBC: Annie Hubert
Director, European Public Policy
Alliance for Regenerative Medicine

TBC: Keith Thompson, CEO, Cell and Gene Therapy Catapult TBC: Keith Thompson
CEO
Cell and Gene Therapy Catapult

 

 
 
 

DOWNLOAD PROSPECTUS

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com